InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (2 ops.)
Insider track record
CFODisclosed buys
5
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Carole Ferrand, Directrice Financière Groupe. Officer active across 2 companies, notably CAPGEMINI. Cumulatively, 9 disclosures have been recorded. Breakdown: 5 buys · 2 sells. Total volume traded: €186k. History available since 3 October 2021. The latest transaction was disclosed on 18 December 2023 (Cession). Regulator: AMF. The full history is accessible without signup.
Companies and markets linked to Carole Ferrand
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
17.665 shares@ €478.344.1% of flowparts du FCPE "ESOP Capgemini"Hors plateforme de négociation2023DD943609
8,000 shares0ActionHors plateforme de négociation2023DD932352
Canonical exit: 10 Jan 2024 (T+90)
8,000 shares0ActionHors plateforme de négociation2023DD932594
Canonical exit: 5 Jan 2024 (T+90)
1,000 shares@ €177.587786.7% of flowActionEuronext Paris2023DD886969
47.508 shares@ €145.253.4% of flowparts du FCPE "ESOP Capgemni"Hors plateforme de négociation2022DD876999
8,000 shares0ActionHors plateforme de négociation2022DD864821
Canonical exit: 1 Jan 2023 (T+90)
1 shares@ €80.62100.0% of flowActionEuronext Paris2022DD859727
Canonical exit: 5 Dec 2022 (T+90)
73.457 shares@ €163.365.9% of flowparts du FCPE «ESOP Capgemini »Hors plateforme de négociation2021DD813202
7,440 shares0ActionHors plateforme de négociation2021DD773646
Canonical exit: 1 Jan 2022 (T+90)
9 of 9 declarations
About Carole Ferrand
Carole Ferrand is the Group Chief Financial Officer at Capgemini and Sanofi. In this role, she is responsible for the financial management of both companies, including financial planning and risk management. Carole works on optimizing financial resources to support growth and performance. Her expertise in finance is essential for ensuring the financial health of Capgemini and Sanofi.
